Speaker Profile
Ph.D., Co-Founder & CSO, 10x Genomics
Biography
Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, he was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad Laboratories in 2011. Before QuantaLife, Ben served in various positions of increasing responsibility at Lawrence Livermore National Laboratory in the Chemical and Biological Weapons Nonproliferation Program. He has published extensively in his field and holds numerous patents for assays and instrumentation. Ben earned his B.S. in Chemistry and his Ph.D in Chemistry from Deakin University, Australia.
Talk
Single cell and spatial technologies are impacting nearly every aspect of biology. I will present on 10x Genomics' latest advances on all 3 of our major product platforms: Chromium, Visium and Xenium. I will describe our efforts to enable more biology, expand the sets of samples and experiments that can be performed, and increase scale.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Edward Esplin, Invitae
- PMWC Award Ceremony
Pioneer Honoree: Michael Snyder, Stanford
Pioneer Honoree: Kári Stefánsson, deCode Genetics
- Keynote
- Kári Stefánsson, deCode Genetics - Genomic & Multiomic Intervention and Prevention of Disease: Colorectal Cancer
- Edward Esplin, Labcorp Genetics - Multi-omic Characterization of Cancer Development and Progression
Chair: Kathleen Barnes, Oxford Nanopore Tech
- Carol Greider, UCSC
- Orit Rozenblatt-Rosen, Genentech
- Emily Leproust, Twist Biosciences - Imaging and Data Strategies in the Human Tumor Atlas Network (HTAN)
- Sean Hanlon, NIH/HTAN
- Advanced Image Analysis and Data Integration in the Human BioMolecular Atlas Program (HuBMAP)
- Pinaki Sarder, University of Florida - Predicting Disease and Managing Health Through Wearables Technologies (PANEL)
Chair: Michael Snyder, Stanford
- Jessilyn Dunn, Duke
- Noosheen Hashemi, January.ai
- Gil Levy, Assuta Ashdod Hospital - Protein Scoring Empowers Improved Disease Risk Prediction
- Cindy Lawley, Olink
- Multi-omic Interrogation of Organ Systems
Chair: Jessilyn Dunn, Duke
- Gloria Pryhuber, University of Rochester Medical Center
- Chenchen Zhu, Stanford
- Assaf Kacen, PromiseBio - Harnessing Single-Cell Genomics for Precision Disease Intervention
- Ben Hindson, 10x Genomics - Vision for Tomorrow: Pioneer Insights (Audience Qs)
Chair: Cindy Lawley, Olink
- Kári Stefánsson, deCode Genetics
